What are FDA’s Guiding Principles of Good AI Practice in Drug Development?

Here they are: Human-centric by design. The development and use of AI technologies align with ethical and human-centric values.Risk-based approach. The development and use of AI technologies follow a risk-based approach with proportionate validation, risk mitigation, and oversight based on the context of use and determined model risk.Adherence to standards. AI technologies adhere to relevant…

Read More

Shifting Sands Part 3

By GEORGE BEAUREGARD Fifteen months ago, I wrote in The Health Care Blog about the “incoming tide” of early-onset cancer. At that time, the global rise in the incidence of early-onset cancer in younger people that had occurred over three decades had been noticed and was being monitored by researchers, scientists, and other healthcare professionals. Articles on…

Read More